1984
DOI: 10.2337/diabetes.33.6.604
|View full text |Cite
|
Sign up to set email alerts
|

Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
33
0

Year Published

1988
1988
2007
2007

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(35 citation statements)
references
References 0 publications
2
33
0
Order By: Relevance
“…Cellular rayo-inositol depletion has been discussed as a pathogenetic mechanism in diabetic neuropathy (2) and nephropathy (5). The lack of significant changes in the present study does not accord with this concept, but confirms recent findings of Loy et al (28).…”
Section: Trimethylaminessupporting
confidence: 80%
See 1 more Smart Citation
“…Cellular rayo-inositol depletion has been discussed as a pathogenetic mechanism in diabetic neuropathy (2) and nephropathy (5). The lack of significant changes in the present study does not accord with this concept, but confirms recent findings of Loy et al (28).…”
Section: Trimethylaminessupporting
confidence: 80%
“…to be involved in the pathomechanisms of diabetic Beyer-Mears et al found a sorbitol accumulation in complications. Thus sorbitol accumulation in various glomeruli of diabetic rats, which was reversed by cells was shown to correlate with diabetic ophthal-treatment with an aldose reductase inhibitor (5). Inmopathy and neuropathy (1).…”
Section: Introductionmentioning
confidence: 99%
“…This conclusion may in agreement with the Mizutani et al report [36] , which stated that selective Müller cell functional abnormalities in early stage of the development of diabetic retinopathy, and with the report of Dubois et al [37] , who found Müller cells death causes retinal dysplasia, photoreceptor apopotosis, and finally retinal degeneration and proliferation of the retinal pigment epithelium. Another reason that reinforce the concept of retinal degeneration by sorbitol pathway is the protection or delaying of diabetic retinopathy by using aldose reductase inhibitor (tolrestat) in diabetic rats [14] , prevention of glomerular disease by aldose reductase inhibitor (sorbinil) in diabetic rats [38] , correcting corneal endothelial changes in diabetic patient by topical aldose reductase inhibitor (placebo) in diabetic patients [39] , Prevention of diabetic complications and nerve tissue by aldose reductase inhibitors (sorbinil or sulindac) in rats lens [40] , prevention of diabetic retinopathy by aldose reductase inhibitor (sorbinil) in diabetic patients [41] , and prevention of basement membrane thickening by aldose reductase inhibitor (sorbinil) in retina of galactosemic rats [3] .…”
Section: Discussionmentioning
confidence: 97%
“…Beyer-Mears et al [15] reported in 1984 that 6 weeks after the induction of diabetes the glomerular sorbitol content had increased while the myo-inositol content had decreased and that these alterations were normalized by sorbinil treatment. These findings have led to the suggestion that gtomerular hyperfiltration in diabetes may be linked to enhanced polyol pathway activity.…”
Section: Discussionmentioning
confidence: 99%